Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

Icahn School of Medicine at Mount Sinai, New York

Weill Cornell Medicine, New York

University of Maryland Medical Center, Baltimore

Virginia Cancer Specialists, Fairfax

West Virginia University, Morgantown

Emory University Winship Cancer Institute, Atlanta

University of Alabama at Birmingham, Birmingham

Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis

Henry Ford Cancer Institute, Detroit

Medical College of Wisconsin, Milwaukee

University of Kansas Cancer Center, Fairway

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas

UT Southwestern Medical Center, Dallas

UT Health San Antonio, San Antonio

Texas Oncology, Austin

Rocky Mountain Cancer Center, Aurora

Arizona Oncology Associates, PC--HOPE Division, Tucson

City of Hope Medical Center, Duarte

Univeristy of California San Francisco HDF Comprehensive Cancer Center, San Francisco

UC Davis Comprehensive Cancer Center, Sacramento

Willamette Valley Cancer Institute and Research Center, Eugene

Massachusetts General Hospital, Boston